VANCOUVER, Jan. 28, 2019 /CNW/ - WELL Health Technologies Corp. (TSXV: WELL) ("WELL" or the "Company"), an owner operator of a portfolio of Primary Healthcare facilities and an Electronic Medical Record service provider; further positioning itself for M&A opportunities in Primary Healthcare and Digital Health marketplaces, announced today that Hamed Shahbazi, CEO, will present at the upcoming Cantech Investment Conference, which is being held on January 29-30, 2019 in Toronto.
Mr. Shahbazi will discuss the Company's recent acquisition of NerdEMR, as well as present an overview of WELL's business, proven blueprint M&A strategy, and its overarching objective to empower primary care doctors to provide the best and most advanced care possible while leveraging the latest trends in digital health.
WELL is scheduled to present on January 29, 2019 at 2:30 PM EST on the TSX Stage and Mr. Shahbazi will also be a member of the "Tech Companies Disrupting The Healthcare Sector" panel at 2:00 PM EST on the TSX stage. Mr. Shahbazi will be available for one on one meetings throughout the conference.
About Cantech Investment Conference 2019
Cantech Investment Conference 2019 is Canada's largest technology investment conference, which is expected to bring together 3,500 engaged investors with more than 100 leading technology companies. The conference will be held on Tuesday & Wednesday, January 29-30, 2019 at the Metro Toronto Convention Centre, 255 Front Street West, Toronto, Canada. The Conference hours will be from 8:00 AM – 5:00 PM EST. For more information, please visit www.cambridgehouse.com.
About WELL Health Technologies Corp.
Backed by legendary investor and business magnate Sir Li Ka‐shing, WELL owns and operates Primary Healthcare Facilities and an Electronic Medical Record service provider in Canada. WELL's overarching objective is to empower primary care doctors to provide the best and most advanced care possible while leveraging the latest trends in digital health. WELL physicians serve approximately 600,000 patient visits per year through its network of 19 medical clinics. WELL is publicly traded on the TSX Venture Exchange under the symbol WELL.V. WELL was recognized as a TSX Venture 50 Company in 2018.
This news release may contain "forward-looking statements" within the meaning of applicable securities laws. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause future results, performance or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by those forward-looking statements and the forward-looking statements are not guarantees of future performance. WELL Health Technologies' expressed or implied by these forward-looking statements are subject to a number of risks, uncertainties and conditions, many of which are outside of WELL Health Technologies Corp's control. For a description of the risks associated with WELL Health Technologies' business please refer to the "Risk Factors" section of WELL Health Technologies' annual information form dated March 6, 2018 which is available at www.sedar.com. Except as required by law, WELL Health Technologies disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, events or otherwise.
SOURCE WELL Health Technologies Corp.
For further information: Pouya Farmand, Pfarmand@gravitassecurities.com, (778) 867-4726